US-licensed clinicians · Compounded in a licensed US 503A pharmacy · Free, discreet delivery
IMPORTANT SAFETY INFORMATION
Your safety comes first. Here’s what to know about this medication, its side effects and other important information before you start.
i
Oral tirzepatide capsules are a compounded medication prepared by a licensed US 503A pharmacy. They are not FDA-approved, and FDA has not evaluated them for safety, effectiveness or quality. They are not the same as Zepbound® or Mounjaro®. The safety information below is based on the known risks of tirzepatide. Your clinician will review your health history and tell you whether this medication is right for you.
Common side effects
Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain
Indigestion (dyspepsia)
Fatigue
Allergic (hypersensitivity) reactions
Burping (eructation)
Hair loss
Acid reflux (GERD)
WARNING: RISK OF THYROID C-CELL TUMORS
In studies in rats, tirzepatide caused thyroid C-cell tumors. It is not known whether tirzepatide causes thyroid tumors, including medullary thyroid carcinoma (MTC), in people.
Do not use oral tirzepatide if you or a family member has ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician right away if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Do not take oral tirzepatide if:
You or a family member has had medullary thyroid carcinoma (MTC), or you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
You have type 1 diabetes
You have had pancreatitis
You have severe stomach problems, such as slowed stomach emptying (gastroparesis) or trouble digesting food
You are allergic to tirzepatide, any other GLP-1 medication, or any ingredient in the capsule [capsule ingredients to be listed by the pharmacy]
You have a history of suicide attempts or active suicidal thoughts
You are taking another tirzepatide product or any other GLP-1 medication
Warnings and precautions
Pancreatitis
Stop taking oral tirzepatide and contact your clinician right away if you have severe stomach pain that won’t go away, with or without vomiting.
Gallbladder problems
Gallbladder problems, including gallstones, have happened with tirzepatide. Tell your clinician if you have pain in your upper stomach, fever, yellowing of your skin or eyes, or clay-colored stools.
Severe stomach and bowel side effects
Tirzepatide can cause stomach and bowel side effects that are sometimes severe. It has not been studied in people with severe gastrointestinal disease and is not recommended for them.
Low blood sugar (hypoglycemia)
Your risk is higher if you also take insulin or a sulfonylurea. Signs include dizziness, shakiness, sweating, confusion, fast heartbeat and blurred vision.
Kidney problems
Diarrhea, nausea and vomiting can cause dehydration, which may lead to kidney problems. Drink plenty of fluids.
Serious allergic reactions
Stop taking oral tirzepatide and get medical help right away if you have swelling of your face, lips, tongue or throat, trouble breathing, a severe rash or a very fast heartbeat.
Birth control
Tirzepatide may make birth control pills work less well. If you use birth control pills, switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each strength increase.
Pregnancy
Tirzepatide may harm an unborn baby. Stop taking it if you become pregnant, and stop at least 2 months before a planned pregnancy.
Diabetic retinopathy
If you have type 2 diabetes and a history of diabetic eye disease, tell your clinician about any changes in your vision.
Depression or suicidal thoughts
Watch for new or worsening depression, suicidal thoughts or unusual changes in mood or behavior, and tell your clinician right away.
Surgery or procedures
Tell every healthcare provider that you take oral tirzepatide before any planned surgery or procedure that uses anesthesia or deep sedation, because food may stay in your stomach longer.
Side effects
The most common side effects of tirzepatide include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, fatigue, allergic reactions, burping, hair loss and acid reflux. These are not all the possible side effects. Talk to your clinician about any side effect that bothers you or doesn’t go away.
To report a suspected side effect, contact your care team, or contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Drug interactions
Tirzepatide slows how quickly food leaves your stomach, which can change how your body absorbs other medicines you take by mouth. Tell your clinician about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
Use in specific populations
Pregnancy
May harm an unborn baby. Stop taking oral tirzepatide if you become pregnant.
Birth control pills
Switch to a non-oral method, or add a barrier method, for 4 weeks after you start and for 4 weeks after each strength increase.
Planning a pregnancy
Stop oral tirzepatide at least 2 months before a planned pregnancy, because it stays in your body for a long time.
Breastfeeding
Talk to your clinician before taking oral tirzepatide if you are breastfeeding or plan to breastfeed.
This is not a complete list of risks. Ask your clinician or pharmacist if you have any questions about your medication. Journi connects patients with independent, US-licensed healthcare providers and does not practise medicine. If you have a medical emergency, call 911.
© 2026 Journi
US-licensed clinicians · Compounded in a licensed US 503A pharmacy · Free, discreet delivery
IMPORTANT SAFETY INFORMATION
Your safety comes first. Here’s what to know about this medication, its side effects and other important information before you start.
i
Oral tirzepatide capsules are a compounded medication prepared by a licensed US 503A pharmacy. They are not FDA-approved, and FDA has not evaluated them for safety, effectiveness or quality. They are not the same as Zepbound® or Mounjaro®. The safety information below is based on the known risks of tirzepatide. Your clinician will review your health history and tell you whether this medication is right for you.
Common side effects
Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain
Indigestion (dyspepsia)
Fatigue
Allergic (hypersensitivity) reactions
Burping (eructation)
Hair loss
Acid reflux (GERD)
WARNING: RISK OF THYROID C-CELL TUMORS
In studies in rats, tirzepatide caused thyroid C-cell tumors. It is not known whether tirzepatide causes thyroid tumors, including medullary thyroid carcinoma (MTC), in people.
Do not use oral tirzepatide if you or a family member has ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician right away if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Do not take oral tirzepatide if:
You or a family member has had medullary thyroid carcinoma (MTC), or you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
You have type 1 diabetes
You have had pancreatitis
You have severe stomach problems, such as slowed stomach emptying (gastroparesis) or trouble digesting food
You are allergic to tirzepatide, any other GLP-1 medication, or any ingredient in the capsule [capsule ingredients to be listed by the pharmacy]
You have a history of suicide attempts or active suicidal thoughts
You are taking another tirzepatide product or any other GLP-1 medication
Warnings and precautions
Pancreatitis
Stop taking oral tirzepatide and contact your clinician right away if you have severe stomach pain that won’t go away, with or without vomiting.
Gallbladder problems
Gallbladder problems, including gallstones, have happened with tirzepatide. Tell your clinician if you have pain in your upper stomach, fever, yellowing of your skin or eyes, or clay-colored stools.
Severe stomach and bowel side effects
Tirzepatide can cause stomach and bowel side effects that are sometimes severe. It has not been studied in people with severe gastrointestinal disease and is not recommended for them.
Low blood sugar (hypoglycemia)
Your risk is higher if you also take insulin or a sulfonylurea. Signs include dizziness, shakiness, sweating, confusion, fast heartbeat and blurred vision.
Kidney problems
Diarrhea, nausea and vomiting can cause dehydration, which may lead to kidney problems. Drink plenty of fluids.
Serious allergic reactions
Stop taking oral tirzepatide and get medical help right away if you have swelling of your face, lips, tongue or throat, trouble breathing, a severe rash or a very fast heartbeat.
Birth control
Tirzepatide may make birth control pills work less well. If you use birth control pills, switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each strength increase.
Pregnancy
Tirzepatide may harm an unborn baby. Stop taking it if you become pregnant, and stop at least 2 months before a planned pregnancy.
Diabetic retinopathy
If you have type 2 diabetes and a history of diabetic eye disease, tell your clinician about any changes in your vision.
Depression or suicidal thoughts
Watch for new or worsening depression, suicidal thoughts or unusual changes in mood or behavior, and tell your clinician right away.
Surgery or procedures
Tell every healthcare provider that you take oral tirzepatide before any planned surgery or procedure that uses anesthesia or deep sedation, because food may stay in your stomach longer.
Side effects
The most common side effects of tirzepatide include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, fatigue, allergic reactions, burping, hair loss and acid reflux. These are not all the possible side effects. Talk to your clinician about any side effect that bothers you or doesn’t go away.
To report a suspected side effect, contact your care team, or contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Drug interactions
Tirzepatide slows how quickly food leaves your stomach, which can change how your body absorbs other medicines you take by mouth. Tell your clinician about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
Use in specific populations
Pregnancy
May harm an unborn baby. Stop taking oral tirzepatide if you become pregnant.
Birth control pills
Switch to a non-oral method, or add a barrier method, for 4 weeks after you start and for 4 weeks after each strength increase.
Planning a pregnancy
Stop oral tirzepatide at least 2 months before a planned pregnancy, because it stays in your body for a long time.
Breastfeeding
Talk to your clinician before taking oral tirzepatide if you are breastfeeding or plan to breastfeed.
This is not a complete list of risks. Ask your clinician or pharmacist if you have any questions about your medication. Journi connects patients with independent, US-licensed healthcare providers and does not practise medicine. If you have a medical emergency, call 911.
© 2026 Journi